Medifast, the parent company of direct selling brand OPTAVIA, announced the addition of three new members to its Scientific Advisory Board. With these additions, Medifast’s Scientific Advisory Board now includes seven internationally recognized experts who will guide the company to make informed decisions based on scientific developments in health and wellness.
The newly appointed board members include:
- Dr. Nikhil Dhurandhar: A physician and nutritional biochemist with more than 38 years of experience who has included the use of lifestyle interventions in his treatment of more than 15,000 patients with obesity
- Dr. Graham Thomas: His research focuses on the use of technology for the assessment and treatment of health behaviors, which he applies when developing AI-powered behavioral intervention research and digital health technologies
- Dr. Jessica Unick: Her weight loss research focuses on adapting behavioral interventions for early non-responders and the impact of physical activity.
“Medifast’s Scientific Advisory Board’s scope has expanded beyond weight loss and nutrition to include behavioral health and health-focused technology,” said Dan Chard, Chairman and CEO of Medifast. “OPTAVIA’s clinically proven plans are designed with input from our distinguished board members and help over one million people annually transform their lives. As consumers seek evidence-based tools and individualized support, more and more people are turning to OPTAVIA as the solution to help them achieve their health goals.”